Literature DB >> 3528862

Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC.

A S Rosenberg, T Mizuochi, A Singer.   

Abstract

The T-cell subpopulations which initiate and mediate tissue allograft rejection remain controversial. In the present study we attempted to identify the phenotype and function of the T-cell subset(s) primarily responsible for the rejection of skin allografts differing at a single class I locus in the major histocompatibility complex (MHC). We found that the rejection rates by B6 mice (H-2b) of four different class I mutant (Kbm) skin allografts form a distinct hierarchy. This hierarchy correlates strikingly and uniquely with the relative precursor frequencies of Lyt2+ interleukin-2-secreting T-helper cells reactive against the various Kbm mutants. To investigate the role of Lyt2+ T cells in the rejection of class I-disparate skin allografts directly, H-2b nude mice were engrafted with Kbm skin allografts and then reconstituted with L3T4+ or Lyt2+ T-cell subpopulations from syngeneic H-2b mice. Lyt2+ T cells were observed to be both necessary and sufficient for the rejection of class I-disparate Kbm skin allografts, whereas L3T4+ T cells were neither necessary nor sufficient. These results identify the Lyt2+ interleukin-2-secreting T-cell subset as the critical cell type determining the rejection rate of class I-disparate Kbm skin allografts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3528862     DOI: 10.1038/322829a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  23 in total

Review 1.  T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection.

Authors:  H Auchincloss; T Mayer; R Ghobrial; H J Winn
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts.

Authors:  R B Mannon; B L Kotzin; C Nataraj; K Ferri; E Roper; R J Kurlander; T M Coffman
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

3.  Detection of new MHC mutations in mice by skin grafting, tumor transplantation and monoclonal antibodies: a comparison.

Authors:  I K Egorov; O S Egorov
Journal:  Genetics       Date:  1988-02       Impact factor: 4.562

4.  The survival and turnover of mature and immature CD8 T cells.

Authors:  M McDonagh; E B Bell
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

5.  The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.

Authors:  H Auchincloss; R Lee; S Shea; J S Markowitz; M J Grusby; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

6.  Functional expression of a heterologous major histocompatibility complex class I gene in transgenic mice.

Authors:  C Bieberich; T Yoshioka; K Tanaka; G Jay; G Scangos
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

7.  Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies.

Authors:  S Sriram; D J Topham; S K Huang; M Rodriguez
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  The cellular basis of the local graft-versus-host reaction in rat kidney.

Authors:  E M Bolton; J A Gracie; L A O'Reilly; J A Bradley
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

9.  Local immunosuppressive therapy with monoclonal anti-T cell antibody on renal allograft survival in the rat.

Authors:  C J Lee; N Yoshimura; O Shiho; M Kita; T Oka
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

10.  T-cell activation, proliferation, and memory after cardiac transplantation in vivo.

Authors:  N D Jones; A Van Maurik; M Hara; B J Gilot; P J Morris; K J Wood
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.